Gent,
I agree with you. Nothing that I have seen in the past 24 hours has changed my mind about my investment in DECN. The negatives being pointed out are the reasons why DECN is trading at the price it is trading at. If they can sell the heck out of their glucose strips, then much of this will be corrected and forgotten and I am hoping they will improve their transparency. If they can't make any progress in the next year in getting some significant revenues, I will probably have a different opinion of the company. But especially since they have won against J&J and now have the ability to sell their product again, I am willing to overlook the negatives, for now, and wait and see if they can deliver on revenues and profits.
An $8 price target seems a bit high to me though. I can see them making between 5 ant 10 cents a share on an outstanding share count of anywhere from 50 to 100 million. With a PE of 20 to 30, that would be a share price range of $1 to $3 per share.
News 
Market Data 
Discover 
